NICE
NICE to collect its own patient data
November 6, 2008Sales and Marketing NICE
NICE's chairman Prof Sir Michael Rawlins has revealed some details of how it will change to ensure more patients will …
Medicine top-ups to be allowed
November 5, 2008Sales and Marketing NICE, par
The ban on NHS patients using top-up payments to receive privately-prescribed medicines has been lifted in a move aimed at …
Alzheimer’s companies hope renewed by House of Lords
October 30, 2008Sales and Marketing Alzheimer's, NICE
The companies behind Alzheimer's drug Aricept have won the right to see the economic model NICE used to assess the …
GSK’s pricing deal for Tyverb fails to sway NICE
October 15, 2008Sales and Marketing GSK, NICE, breast cancer
NICE has spurned GSK's risk-sharing proposal for its breast cancer treatment Tyverb, saying the drug is still too expensive to …
Pradaxa approved by NICE
September 26, 2008Sales and Marketing NICE, Pradaxa, clot, cv
NICE has recommended Boehringer Ingelheim's novel anti-clotting pill Pradaxa, giving it a marketing edge over Bayer's rival treatment Xarelto. Pradaxa …
The Pharmafocus Interview: Andrew Dillon
September 17, 2008Research and Development, Sales and Marketing NHS, NICE, hc
NICE's rejection of four new cancer drugs predictably provoked the ire of campaigners, again raising unfavourable comparisons with European uptake …
GSK seeks risk-sharing deal for Tyverb
September 17, 2008Sales and Marketing Cancer, GSK, NICE, par
GlaxoSmithKline has approached the government for a new pricing deal on its breast cancer drug Tyverb, which could make it …
Latest news from Datamonitor
September 15, 2008Sales and Marketing NICE, rcc
UK watchdog's guidance knocks kidney cancer drugsThe UK's cost-effectiveness watchdog NICE has delivered another blow to the developers of targeted …
Government looks set to allow top-up fees
September 10, 2008Sales and Marketing Cancer, Karol Sikora, NICE
Patients in the UK could soon gain official clearance to pay ‘top up’ fees in order to receive the cancer …
The Pharmafocus Interview: Martin Dawkins
September 4, 2008Research and Development, Sales and Marketing Bayer, Cancer, NICE, Xarelto, healthcare
Martin Dawkins is an Englishman born and bred, but has spent most of his career working abroad, including the US, …
A faster NICE and a ‘right’ to drug access in NHS Constitution
July 1, 2008Sales and Marketing NICE
The problem of access to new cancer treatments and other medicines is to be addressed as part of the newly …
Close to home: the UK’s regional NHS influencers
June 3, 2008Sales and Marketing NICE, UK, healthcare, influencers, regional
With so much attention directed at NICE since the parliamentary health select committee reported on the organisation in January, it …
Working with NICE: the ingredients for success
February 29, 2008Research and Development, Sales and Marketing NICE, healthcare, industry relations, pharma
NICE fascinates everyone in the industry, and NICE knows only too well that every move it makes is studied by …
NICE bends to pressure over Lucentis
December 14, 2007Sales and Marketing AMD, Lucentis, NICE
NICE is set to change its guidance for blindness treatment Lucentis following a barrage of complaints over its failure to …
Eisai gets go ahead for Alzheimer’s appeal
December 10, 2007Alzheimer's, Eisai, NICE
Eisai is to make one more legal challenge to NICE by taking its case on Alzheimer’s drugs to the Court …
